Sarcoidosis: Are There Differences in Your Skin of Color Patients?

The document reviewed the differences in sarcoidosis presentation and prognosis in patients with skin of color, particularly Black patients, who experienced more severe disease and poorer long-term outcomes compared to Caucasians. Black patients often presented with advanced disease, including more frequent pulmonary involvement and relapses. The review emphasized the importance of recognizing diverse cutaneous manifestations, such as lupus pernio, hypopigmented macules, and ichthyosiform lesions, to improve diagnosis and treatment. Treatment options included corticosteroids, antimalarials, and methotrexate, with attention to potential side effects and the need for early recognition and systemic evaluation. The study highlighted the need for enhanced education and resources in dermatology to address these disparities.